Le, Caroline P.
Nowell, Cameron J.
Kim-Fuchs, Corina
Botteri, Edoardo
Hiller, Jonathan G.
Ismail, Hilmy
Pimentel, Matthew A.
Chai, Ming G.
Karnezis, Tara
Rotmensz, Nicole
Renne, Giuseppe
Gandini, Sara
Pouton, Colin W.
Ferrari, Davide
Möller, Andreas
Stacker, Steven A.
Sloan, Erica K.
Article History
Received: 3 August 2015
Accepted: 4 January 2016
First Online: 1 March 2016
Competing interests
: S.A.S. is a shareholder in Circadian Technologies and Ark Therapeutics. The remaining authors declare no competing financial interests.